1Treellion Global Funds was founded by Tali Orad and Angela Guerra in September 2019, aiming to plant our planet together with communities. With that improve the communities quality of life while mitigating climate change. 

Tali Orad

Tali Orad is a serial entrepreneur, engineer, and changemaker.


Besides being the co-founder of 1treellion, she is the co-founder of Wibble a social media/ marketplace for influential vloggers to engage authentically with their viewers.

Prior to Wibble, a founder and CEO of Screen - an IoT startup with the mission to help families strike a healthy balance with their electronic devices. As a sole female founder Tali raised $2MM, built a team, developed the hardware & software prototype, and by raising awareness to the problem was part of  those who managed to change this market. As a thought leader in the space Tali speaks in various schools and conferences, including The Girl Scouts convention and participated in panels with Facebook, Instagram and more.

Tali’s previous NGO came about  after she saved the life of a dying child, resulting in her founding an NGO to raise awareness to CPR education. The organization also connects local EMTs with elementary school children to teach them the basic skills of choking prevention.

Tali believes in the power of people to make a change, and hoping with the help of the people she can help our planet.

Tali Orad 2 - Copy.jpg

Angela Guerra


Angela Guerra is a Biotech/Pharma business leader. She is passionate about life, loves people & nature and believes in the power of human connection and creative thinking to make things happen.

Angela has deep knowledge of Biotech/Pharma business with both Global & Affiliate experience.
Strong background in Medical Affairs and strategic mindset to build the medical strategy and establish short/long term life cycle management plans and communication frameworks at at different stages of the product’s life cycle
Ability to easily identify data gaps and translate science into relevant and organized information that is applicable in clinical practice settings.
Sound experience in phase 2/3 data readouts and post-marketing safety EU/EMA regulatory processes.

Leadership capabilities and successful results in both direct and indirect teams management.